These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 14726137)

  • 1. Feasibility studies of utilizing disk intrinsic dissolution rate to classify drugs.
    Yu LX; Carlin AS; Amidon GL; Hussain AS
    Int J Pharm; 2004 Feb; 270(1-2):221-7. PubMed ID: 14726137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Miniaturized rotating disk intrinsic dissolution rate measurement: effects of buffer capacity in comparisons to traditional wood's apparatus.
    Avdeef A; Tsinman O
    Pharm Res; 2008 Nov; 25(11):2613-27. PubMed ID: 18648912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miniaturized INtrinsic DISsolution Screening (MINDISS) assay for preformulation.
    Alsenz J; Haenel E; Anedda A; Du Castel P; Cirelli G
    Eur J Pharm Sci; 2016 May; 87():3-13. PubMed ID: 26360839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of agitation force in dissolution test and mechanical destructive force in disintegration test.
    Kamba M; Seta Y; Takeda N; Hamaura T; Kusai A; Nakane H; Nishimura K
    Int J Pharm; 2003 Jan; 250(1):99-109. PubMed ID: 12480276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The random vibration effects on dissolution testing with USP apparatus 2.
    Gao Z; Moore TW; Buhse LF; Doub WH
    J Pharm Sci; 2009 Jan; 98(1):297-306. PubMed ID: 18399543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Powder dissolution method for estimating rotating disk intrinsic dissolution rates of low solubility drugs.
    Tsinman K; Avdeef A; Tsinman O; Voloboy D
    Pharm Res; 2009 Sep; 26(9):2093-100. PubMed ID: 19543816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a physiologic bicarbonate buffer system for dissolution characterization of ionizable drugs.
    McNamara DP; Whitney KM; Goss SL
    Pharm Res; 2003 Oct; 20(10):1641-6. PubMed ID: 14620520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of variability in dissolution testing with USP apparatus 2.
    Gao Z; Moore TW; Smith AP; Doub WH; Westenberger BJ
    J Pharm Sci; 2007 Jul; 96(7):1794-801. PubMed ID: 17252609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of USP apparatus 3 for dissolution testing of immediate-release products.
    Yu LX; Wang JT; Hussain AS
    AAPS PharmSci; 2002; 4(1):E1. PubMed ID: 12049485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
    Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
    Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biopharmaceutical classification of drugs using intrinsic dissolution rate (IDR) and rat intestinal permeability.
    Zakeri-Milani P; Barzegar-Jalali M; Azimi M; Valizadeh H
    Eur J Pharm Biopharm; 2009 Sep; 73(1):102-6. PubMed ID: 19442726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hydrodynamic environment on tablets dissolution rate.
    Wu Y; Kildsig DO; Ghaly ES
    Pharm Dev Technol; 2004; 9(1):25-37. PubMed ID: 15000464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimum rotation speed to prevent coning phenomena in compendium paddle dissolution apparatus.
    Higuchi M; Yoshihashi Y; Tarada K; Sugano K
    Eur J Pharm Sci; 2014 Dec; 65():74-8. PubMed ID: 25240320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid dosage forms for active antiretroviral therapy (HAART): dissolution profile study of nevirapine by experimental factorial design.
    de Oliveira GG; Ferraz H; Severino P; Souto EB
    Pharm Dev Technol; 2013; 18(2):428-33. PubMed ID: 22519303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and suggested improvements of the Biopharmaceutics Classification System (BCS).
    Fagerholm U
    J Pharm Pharmacol; 2007 Jun; 59(6):751-7. PubMed ID: 17637167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the use of a 200 ml vessel suitable for dissolution of low dose drug products?
    Crail DJ; Tunis A; Dansereau R
    Int J Pharm; 2004 Jan; 269(1):203-9. PubMed ID: 14698592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the full potential of the biopharmaceutics classification system reached?
    Bergström CA; Andersson SB; Fagerberg JH; Ragnarsson G; Lindahl A
    Eur J Pharm Sci; 2014 Jun; 57():224-31. PubMed ID: 24075971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of intrinsic dissolution behavior of different carbamazepine samples.
    Sehić S; Betz G; Hadzidedić S; El-Arini SK; Leuenberger H
    Int J Pharm; 2010 Feb; 386(1-2):77-90. PubMed ID: 19900519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the USP dissolution test method A for enteric-coated articles by planar laser-induced fluorescence.
    Miller DA; Gamba M; Sauer D; Purvis TP; Clemens NT; Williams RO
    Int J Pharm; 2007 Feb; 330(1-2):61-72. PubMed ID: 17034967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical properties of direct compression tablets with spray dried and ball milled solid dispersions of tadalafil in PVP-VA.
    Wlodarski K; Tajber L; Sawicki W
    Eur J Pharm Biopharm; 2016 Dec; 109():14-23. PubMed ID: 27658987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.